Skip to main content
OpenTrials
Completed

NCT Number: NCT02345720

Effects of Multifocal Contact Lens on Ocular Tissue

The purpose of this study is to evaluate the etafilcon - PVP (multi-focal)

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

40 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

London, SW1E6AU, United Kingdom

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The subject must read, understand, and sign the statement of Informed Consent and receive a fully executed copy of the form.
  • The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.
  • The subject must be between 40 and 70 years of age.
  • The subject's vertex corrected spherical equivalent distance refraction must be in the range of 1.00 too -5.75 in each eye.
  • The subject must identify themselves as Asian by self-report and have eyes and eyelids with an automatically Asian appearance.
  • The subject's refractive cylinder must be less than or equal to -0.75D in each eye.
  • The subject's ADD power must be in the range of +0.75 D to +2.5 D in each eye.
  • The subject must have best corrected visual acuity of 20/20-3 or better in each eye.
  • Subjects own a wearable pair of spectacles, if required for their distance vision.
  • The subject must be an adapted soft contact lens wearer in both eyes (i.e. worn lenses a minimum of 5 days per week for at least 8 hours per day, for one month or more duration).
  • The subject must already be wearing a presbyopic contact lens correction (e.g. reading spectacles over contact lenses, multifocal or monovision contact lenses, etc.) or if not respond positively to at least one symptom on the "Presbyopic Symptoms Questionnaire".

Exclusion criteria

  • Currently pregnant or lactating (subjects who become pregnant during the study will be discontinued)
  • Any ocular or systemic allergies that contraindicate contact lens wear.
  • Any ocular or systemic disease, autoimmune disease, or use of medication, that will contraindicate contact lens wear.
  • Any ocular abnormality that may interfere with contact lens wear.
  • Use of any ocular medications, with the exception of rewetting drops.
  • Any previous intraocular surgery (e.g. radial keratotomy, PRK, LASIK, etc.).
  • Any grade 3 or greater slit lamp findings (e.g. edema, corneal neovascularization, corneal staining, tarsal abnormalities, conjunctival injection) which may contraindicate contact lens wear.
  • History of herpetic keratitis.
  • Any ocular infection or inflammation.
  • Any corneal distortion or irregular cornea.
  • History of binocular vision abnormality or strabismus.
  • Any infectious disease (e.g. hepatitis, tuberculosis) or a contagious immunosuppressive disease (e.g. HIV).
  • History of diabetes.
  • Habitual wearer of etafilcon-A contact lens material.
  • Participation in any contact lens or lens care product clinical trial within 30 days prior to study enrollment.

Treatment and study plan

etafilcon - PVP (multi-focal)

Device

The investigational contact lens must be worn at least six hours daily.

Primary outcomes

  1. Upper Eye Lid Margin Staining

    Time frame: 30 days Post wear

    Upper Eye Lid Margin Staining is assessed via Ocular Photography using proprietary algorithm. The average grade across upper eye lid margin was reported in mm^2.

  2. Limbal Staining

    Time frame: 30 Days Post Wear

    Measured via Ocular Photography using proprietary algorithm. The limbal conjunctival lissamine green staining average surface area in % of the overall limbal area was reported.

  3. Corneal Staining

    Time frame: 30 Days Post Wear

    The corneal fluorescein staining average surface area in % of the upper corneal quadrant was reported.

Sponsors and collaborators

Lead sponsor

Johnson & Johnson Vision Care, Inc.

Industry

Registry information

Official study title

Effects on Ocular Tissues of Vistakon® Investigational Multifocal Contact Lenses - Asian Population Study

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Jan 26, 2015
Registry last updated
Jun 19, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.